NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues
Author:
Funder
Hamad Medical Corporation
Publisher
Elsevier BV
Subject
Hepatology
Reference8 articles.
1. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study;Ji;J Hepatol,2020
2. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020
3. Metabolic-associated fatty liver disease is associated with severity of COVID-19;Zhou;Liver Int,2020
4. Overweight and obesity in eastern mediterranean region: prevalence and possible causes;Musaiger;J Obes,2011
5. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease;Lee;Dig Liver Dis,2010
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19;World Journal of Gastroenterology;2024-08-21
2. Is Steatotic Liver Disease Related to Poor Outcome in COVID-19-Hospitalized Patients?;Journal of Clinical Medicine;2024-05-03
3. Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?;Biomedicines;2024-01-26
4. Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines;Life;2024-01-07
5. Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective study;eBioMedicine;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3